InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Clark Eliana, Directeur Exécutif, Technologie. Director active across 1 company, notably Intellia Therapeutics, Inc.. Aggregated, 13 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €125k. Activity tracked since 1 March 2022. The latest transaction was disclosed on 1 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Clark Eliana is Directeur Exécutif, Technologie at Intellia Therapeutics, Inc. The 13 filings on record, all within the sampled set, cover the period from 2022-03-07 to 2026-03-03 and show EUR 0 of buys and EUR 125481 of sells, with Cession as the most frequent transaction type.